P

Inventor

NARA SUSHEEL JETHANAND

IN28 patents
⚠️ This page may combine multiple inventors who share the name “NARA SUSHEEL JETHANAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

27 patents
US9790169B2Oct 17, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO19 citations91
US10959986B2Mar 30, 2021

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO3 citations72
US10399933B2Sep 3, 2019

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

BRISTOL MYERS SQUIBB CO3 citations72
US10253027B2Apr 9, 2019

Aryl lactam kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US9708337B2Jul 18, 2017

Aryl amide-based kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US10399932B2Sep 3, 2019

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019

IDO inhibitors

BRISTOL MYERS SQUIBB CO1 citations71
US11713312B2Aug 1, 2023

Substituted bicyclic compounds as farnesoid X receptor modulators

BRISTOL MYERS SQUIBB CO2 citations70
US11254663B2Feb 22, 2022

Substituted bicyclic compounds as farnesoid X receptor modulators

BRISTOL MYERS SQUIBB CO2 citations70
US11337970B2May 24, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations62
US10544120B2Jan 28, 2020

Biaryl kinase inhibitors

BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019

Biaryl kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations62
US12145927B2Nov 19, 2024

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US12269819B2Apr 8, 2025

Small molecule inhibitors of Galectin-3

BRISTOL MYERS SQUIBB CO0 citations51
US12059420B2Aug 13, 2024

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO0 citations51
US9932320B2Apr 3, 2018

Quinoline-based kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US8969564B2Mar 3, 2015

Aryl ether-base kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US8901305B2Dec 2, 2014

Aryl lactam kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US8703953B2Apr 22, 2014

Aryl ether-base kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US12319676B2Jun 3, 2025

Substituted amide compounds useful as farnesoid X receptor modulators

BRISTOL MYERS SQUIBB CO0 citations48
US12286424B2Apr 29, 2025

Small molecule inhibitors of galectin-3

BRISTOL MYERS SQUIBB CO0 citations47
US12030835B2Jul 9, 2024

Substituted amide compounds useful as farnesoid X receptor modulators

BRISTOL MYERS SQUIBB CO0 citations47
US12227496B2Feb 18, 2025

Substituted bicyclic compounds as farnesoid X receptor modulators

BRISTOL MYERS SQUIBB CO0 citations46
US10035777B2Jul 31, 2018

Heterocyclic kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations41
US10730863B2Aug 4, 2020

Bridged bicyclic compounds as farnesoid X receptor modulators

BRISTOL MYERS SQUIBB CO0 citations38
US10174044B2Jan 8, 2019

Fused pyridines as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations37

BRISTOL MYERS SQUIBB

1 patent